图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Pediatric Rhabdomyosarcoma

卷 20, 册 3-4, 2015, pp. 227-243
DOI: 10.1615/CritRevOncog.2015013800
Get accessGet access

摘要

Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood, and despite clinical advances, subsets of these patients continue to suffer high levels of morbidity and mortality associated with their disease. Recent genetic and molecular characterization of these tumors using sophisticated genomics techniques, including next-generation sequencing experiments, has revealed multiple areas that can be exploited for new molecularly targeted therapies for this disease.

对本文的引用
  1. Rengaswamy Venkatesh, Zimmer Doris, Süss Regine, Rössler Jochen, RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy, Journal of Controlled Release, 235, 2016. Crossref

  2. Adamus Anna, Peer Katharina, Ali Iftikhar, Lisec Jan, Falodun Abiodun, Frank Marcus, Seitz Guido, Engel Nadja, Berberis orthobotrys – A promising herbal anti-tumorigenic candidate for the treatment of pediatric alveolar rhabdomyosarcoma, Journal of Ethnopharmacology, 229, 2019. Crossref

  3. Rashed Wafaa M., C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview, Critical Reviews in Oncology/Hematology, 131, 2018. Crossref

  4. Genadry Katia C., Pietrobono Silvia, Rota Rossella, Linardic Corinne M., Soft Tissue Sarcoma Cancer Stem Cells: An Overview, Frontiers in Oncology, 8, 2018. Crossref

  5. Vega Carolina, Liu Yang, Arora Rajan, Vaginal mass presenting to a paediatric emergency department, Emergency Medicine Journal, 36, 8, 2019. Crossref

  6. Sanna Luca, Piredda Roberta, Marchesi Irene, Bordoni Valentina, Forcales Sonia Vanina, Calvisi Diego Francesco, Bagella Luigi, “Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines”, Chemico-Biological Interactions, 312, 2019. Crossref

  7. Pal Ananya, Chiu Hsin Yao, Taneja Reshma, Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics, Redox Biology, 25, 2019. Crossref

  8. Yohe Marielle E., Heske Christine M., Stewart Elizabeth, Adamson Peter C., Ahmed Nabil, Antonescu Cristina R., Chen Eleanor, Collins Natalie, Ehrlich Alan, Galindo Rene L., Gryder Berkley E., Hahn Heidi, Hammond Sharon, Hatley Mark E., Hawkins Douglas S., Hayes Madeline N., Hayes-Jordan Andrea, Helman Lee J., Hettmer Simone, Ignatius Myron S., Keller Charles, Khan Javed, Kirsch David G., Linardic Corinne M., Lupo Philip J., Rota Rossella, Shern Jack F., Shipley Janet, Sindiri Sivasish, Tapscott Stephen J., Vakoc Christopher R., Wexler Leonard H., Langenau David M., Insights into pediatric rhabdomyosarcoma research: Challenges and goals, Pediatric Blood & Cancer, 66, 10, 2019. Crossref

  9. Xu Ning, Hua Zhongyan, Ba Gen, Zhang Simeng, Liu Zhihui, Thiele Carol J., Li Zhijie, The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo, Journal of Experimental & Clinical Cancer Research, 38, 1, 2019. Crossref

  10. Al-Ghabkari Abdulhameed, Qasrawi Deema O., Alshehri Mana, Narendran Aru, Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration, Journal of Cancer Research and Clinical Oncology, 145, 6, 2019. Crossref

  11. Issaq Sameer H., Mendoza Arnulfo, Fox Stephen D., Helman Lee J., Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth, Oncogenesis, 8, 3, 2019. Crossref

  12. Siddiqui Sana H., Siddiqui Emaad, Bavier Rich D., Patel Nirali M., Kiliç Suat, Baredes Soly, Hsueh Wayne D., Eloy Jean Anderson, Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma, International Forum of Allergy & Rhinology, 9, 4, 2019. Crossref

  13. Kohlmeyer Jordan L, Gordon David J, Tanas Munir R, Monga Varun, Dodd Rebecca D, Quelle Dawn E, CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets, International Journal of Molecular Sciences, 21, 8, 2020. Crossref

  14. Casey Mattie J., Stewart Rodney A., Pediatric Cancer Models in Zebrafish, Trends in Cancer, 6, 5, 2020. Crossref

  15. Sims Danica, Maranyane Hapiloe Mabaruti, Damerell Victoria, Govender Dhirendra, Isaacs Ashwin W., Peres Jade, Prince Sharon, The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma, Cancers, 12, 2, 2020. Crossref

  16. Dombrowski Natasha D., Wolter Nikolaus E., Robson Caroline D., Kawai Kosuke, Irace Alexandria L., Vargas Sara O., Marcus Karen J., Mack Jennifer W., Collins Natalie B., Rahbar Reza, Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children, The Laryngoscope, 131, 3, 2021. Crossref

  17. Zakir Muhammad, Khurshid Ahmat, Khan Muhammad Iqbal, Khattak Asma, Khan Murad Ali, The application of aluminium phthalocyanine AlPs-4-mediated photodynamic therapy against human soft tissue sarcoma (RMS) cell line, Journal of Porphyrins and Phthalocyanines, 25, 02, 2021. Crossref

  18. Hernandez Tejada Fiorela N., Zamudio Alejandro, Marques-Piubelli Mario L., Cuglievan Branko, Harrison Douglas, Advances in the Management of Pediatric Sarcomas, Current Oncology Reports, 23, 1, 2021. Crossref

  19. Mur Taha A., Pellegrini William R., Jaleel Zaroug, Edwards Heather A., Levi Jessica R., Pediatric laryngeal sarcoma: Systematic review and pooled analysis, International Journal of Pediatric Otorhinolaryngology, 139, 2020. Crossref

  20. Nithya S., Saxena Susmita, Kharbanda Jitin, Oral pediatric pathologies: Incidence and demography – An institutional study in Delhi, India, Indian Journal of Medical Sciences, 71, 2020. Crossref

  21. Sobral Lays M., Hicks Hannah M., Parrish Janet K., McCann Tyler S., Hsieh Joseph, Goodspeed Andrew, Costello James C., Black Joshua C., Jedlicka Paul, KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma, Molecular Oncology, 14, 10, 2020. Crossref

  22. Du Shutong, Meng Lian, Song Lingxie, Zhang Pengpeng, Shou Xi, Liu Chunxia, Li Feng, Safety markers for rhabdomyosarcoma cells using an in�vivo imaging system, Oncology Letters, 2018. Crossref

  23. Martin Sobral Lays, Sechler Marybeth, Parrish Janet K., McCann Tyler S., Jones Kenneth L., Black Joshua C., Jedlicka Paul, KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma, Genes & Cancer, 11, 1-2, 2020. Crossref

  24. Choi Joon Hyuk, Ro Jae Y., Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach, Diagnostics, 10, 9, 2020. Crossref

  25. Dehner Carina A., Armstrong Amy E., Yohe Marielle, Shern Jack F., Hirbe Angela C., Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma, Genes, 12, 10, 2021. Crossref

  26. Adamus Anna, Ali Iftikhar, Vasileiadis Vasileios, Al-Hileh Luai, Lisec Jan, Frank Marcus, Seitz Guido, Engel Nadja, Vincetoxicum arnottianum modulates motility features and metastatic marker expression in pediatric rhabdomyosarcoma by stabilizing the actin cytoskeleton, BMC Complementary Medicine and Therapies, 21, 1, 2021. Crossref

  27. Raskin Scott, Angiolillo Anne L., Biological and molecular markers in childhood malignancies, in Biochemical and Molecular Basis of Pediatric Disease, 2021. Crossref

  28. Luo Qi, Zhang Qin, Shen Jinwen, Guan Wenbin, Li Ming, Zhang Jia, Tan Zhen, Expanding mutational spectrum of HRAS by a patient with Schimmelpenning–Feuerstein–Mims syndrome , The Journal of Dermatology, 48, 8, 2021. Crossref

  29. Aghaei Mahmoud, Nasimian Ahmad, Rahmati Marveh, Kawalec Philip, Machaj Filip, Rosik Jakub, Bhushan Bhavya, Bathaie S. Zahra, Azarpira Negar, Los Marek J., Samali Afshin, Perrin David, Gordon Joseph W., Ghavami Saeid, The Role of BiP and the IRE1α–XBP1 Axis in Rhabdomyosarcoma Pathology, Cancers, 13, 19, 2021. Crossref

  30. Pomella Silvia, Sreenivas Prethish, Gryder Berkley E., Wang Long, Milewski David, Cassandri Matteo, Baxi Kunal, Hensch Nicole R., Carcarino Elena, Song Young, Chou Hsien-Chao, Yohe Marielle E., Stanton Benjamin Z., Amadio Bruno, Caruana Ignazio, De Stefanis Cristiano, De Vito Rita, Locatelli Franco, Chen Yidong, Chen Eleanor Y., Houghton Peter, Khan Javed, Rota Rossella, Ignatius Myron S., Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma, Nature Communications, 12, 1, 2021. Crossref

  31. Barros Juliana Sobral, Aguiar Talita Ferreira Marques, Costa Silvia Souza, Rivas Maria Prates, Cypriano Monica, Toledo Silvia Regina Caminada, Novak Estela Maria, Odone Vicente, Cristofani Lilian Maria, Carraro Dirce Maria, Werneck da Cunha Isabela, Costa Cecília Maria Lima, Vianna-Morgante Angela M., Rosenberg Carla, Krepischi Ana Cristina Victorino, Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways, Frontiers in Oncology, 11, 2021. Crossref

  32. Masetti Riccardo, Leardini Davide, Ronchini Laura, Riolo Serena, Guida Fiorentina, Bacelli Francesco, Cerasi Sara, Papaleo Teresa, Bertelli Luca, Pession Andrea, Ostruzioni nasali e russamento: da tre casi insoliti una lezione per il pediatra, Medico e Bambino, 39, 9, 2020. Crossref

  33. Gutierrez Wade R., Scherer Amanda, McGivney Gavin R., Brockman Qierra R., Knepper-Adrian Vickie, Laverty Emily A., Roughton Grace A., Dodd Rebecca D., Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models, Scientific Reports, 11, 1, 2021. Crossref

  34. Perreault Sébastien, Chami Rose, Deyell Rebecca J., El Demellawy Dina, Ellezam Benjamin, Jabado Nada, Morgenstern Daniel A., Narendran Aru, Sorensen Poul H. B., Wasserman Jonathan D., Yip Stephen, Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients, Current Oncology, 28, 1, 2021. Crossref

  35. Bennett Jennifer A., Ordulu Zehra, Young Robert H., Pinto Andre, Van de Vijver Koen, Burandt Eike, Wanjari Pankhuri, Shah Rajeev, de Kock Leanne, Foulkes William D., McCluggage W. Glenn, Ritterhouse Lauren L., Oliva Esther, Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations, Modern Pathology, 34, 9, 2021. Crossref

  36. Xu Mark C., Ghani M. Owais, Apple Annie, Chen Heidi, Whiteside Martin, Borinstein Scott C., Correa Hernan, Lovvorn Harold N., Changes in FXR1 expression after Chemotherapy for Rhabdomyosarcoma, Journal of Pediatric Surgery, 56, 6, 2021. Crossref

  37. Bains Amandeep, Chaudhry Hiba, Hennedige Anusha, Iqbal Mazhar, A Case of Mistaken Identity: The Importance of Recognizing Red Flag Symptoms, Dental Update, 49, 4, 2022. Crossref

  38. Bersani Francesca, Lingua Marcello Francesco, Morena Deborah, Foglizzo Valentina, Miretti Silvia, Lanzetti Letizia, Carrà Giovanna, Morotti Alessandro, Ala Ugo, Provero Paolo, Chiarle Roberto, Singer Samuel, Ladanyi Marc, Tuschl Thomas, Ponzetto Carola, Taulli Riccardo, Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma, Cancer Research, 76, 20, 2016. Crossref

  39. Bhat Akshay V., Palanichamy Kala Monica, Rao Vinay Kumar, Pignata Luca, Lim Huey Jin, Suriyamurthy Sudha, Chang Kenneth T., Lee Victor K., Guccione Ernesto, Taneja Reshma, Epigenetic Regulation of the PTEN–AKT–RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma, Cancer Research, 79, 9, 2019. Crossref

  40. Ahmed Atif A., Farooqi Midhat S., Habeebu Sultan S., Gonzalez Elizabeth, Flatt Terrie G., Wilson Ashley L., Barr Frederic G., NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma, Cancers, 14, 3, 2022. Crossref

  41. Yoon Hye-Young, Maron Ben Y., Girald-Berlingeri Sofia, Gasilina Anjelika, Gollin Josephine C., Jian Xiaoying, Akpan Itoro, Yohe Marielle E., Randazzo Paul A., Chen Pei-Wen, ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell lines, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1869, 8, 2022. Crossref

  42. Haduong Josephine H., Heske Christine M., Allen‐Rhoades Wendy, Xue Wei, Teot Lisa A., Rodeberg David A., Donaldson Sarah S., Weiss Aaron, Hawkins Douglas S., Venkatramani Rajkumar, An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials, Pediatric Blood & Cancer, 69, 4, 2022. Crossref

  43. Kim Jung, Light Nicholas, Subasri Vallijah, Young Erin L., Wegman-Ostrosky Talia, Barkauskas Donald A., Hall David, Lupo Philip J., Patidar Rajesh, Maese Luke D., Jones Kristine, Wang Mingyi, Genome Research Laboratory Cancer, Tavtigian Sean V., Wu Dongjing, Shlien Adam, Telfer Frank, Goldenberg Anna, Skapek Stephen X., Wei Jun S., Wen Xinyu, Catchpoole Daniel, Hawkins Douglas S., Schiffman Joshua D., Khan Javed, Malkin David, Stewart Douglas R., Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma, JCO Precision Oncology, 5, 2021. Crossref

  44. Garcia Natalia, Del Pozo Vanessa, Yohe Marielle E., Goodwin Craig M., Shackleford Terry J., Wang Long, Baxi Kunal, Chen Yidong, Rogojina Anna T., Zimmerman Sara M., Peer Cody J., Figg William D., Ignatius Myron S., Wood Kris C., Houghton Peter J., Vaseva Angelina V., Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma, Molecular Cancer Therapeutics, 21, 1, 2022. Crossref

  45. Aukema Sietse M., Glaser Selina, van den Hout Mari F. C. M., Dahlum Sonja, Blok Marinus J., Hillmer Morten, Kolarova Julia, Sciot Raf, Schott Dina A., Siebert Reiner, Stumpel Constance T. R. M., Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes, Familial Cancer, 2022. Crossref

  46. Fan Rong, Parham David M., Wang Larry L., An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma, Archives of Pathology & Laboratory Medicine, 146, 8, 2022. Crossref

  47. Radzikowska Joanna, Czarnecka Anna M., Klepacka Teresa, Rychłowska-Pruszyńska Magdalena, Raciborska Anna, Dembowska-Bagińska Bożenna, Pronicki Maciej, Kukwa Andrzej, Fendler Wojciech, Smyczyńska Urszula, Kukwa Wojciech, Krzeski Antoni, Cancer Stem Cell Markers in Rhabdomyosarcoma in Children, Diagnostics, 12, 8, 2022. Crossref

  48. Markiz Samer N., Khan Safia, Wagley Zainab B., Viqaruddin Mohammed K., Khafaga Yasser M., AlFawaz Ibrahim A., AlAnazi Awatif E., AlKofide Amani, Khoja Hatem A., Ali Afshan A., Rhabdomyosarcoma in children: Retrospective analysis from a single tertiary care center in Saudi Arabia, Cancer Reports, 2022. Crossref

  49. Sullivan Peter M., Kumar Rajesh, Li Wei, Hoglund Virginia, Wang Lingyan, Zhang Yue, Shi Megan, Beak Dusan, Cheuk Adam, Jensen Michael C., Khan Javed, Dimitrov Dimiter S., Orentas Rimas J., FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma, Molecular Cancer Therapeutics, 21, 10, 2022. Crossref

  50. González-Arboleda Andrés Augusto, Fernandez Nicolás, García-Perdomo Herney Andrés, Genitourinary Tract Tumors in Children: An Update, Current Pediatric Reviews, 18, 3, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain